Cargando…
Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients
BACKGROUND AND AIMS: Animal studies suggested that vildagliptin might exert a beneficial effect on cognitive function. The present study evaluated whether the use of vildagliptin in patients with type 2 diabetes mellitus might affect dementia risk. METHODS: The database of Taiwan’s National Health I...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120263/ https://www.ncbi.nlm.nih.gov/pubmed/33995274 http://dx.doi.org/10.3389/fendo.2021.637392 |